In a randomized , double-blind , placebo-controlled , three-way cross-over study , 18 healthy men received , with an interval of 24 h , two oral doses of 50 mg lumiracoxib or for comparison , 90 mg etoricoxib , for which local tissue accumulation has not been claimed as therapeutic component .